Pentwater Capital Management LP Horizon Therapeutics Public LTD CO Transaction History

Pentwater Capital Management LP

  • $9.58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$98.98 - $115.74 $280 Million - $327 Million
2,825,100 Added 22.2%
15,552,000 $1.8 Billion
Q2 2023

Aug 14, 2023
BUY
$96.34 - $112.38 $638 Million - $745 Million
6,626,900 Added 108.64%
12,726,900 $1.31 Billion
Q1 2023

May 15, 2023
BUY
$107.32 - $113.5 $275 Million - $291 Million
2,560,344 Added 72.33%
6,100,000 $666 Million
Q4 2022

Feb 14, 2023
BUY
$62.39 - $113.8 $221 Million - $403 Million
3,539,656 New
3,539,656 $403 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email